Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2018-01-28565,2018,Suijkerbuijk 2018 PLoS One,6200,Both Hepatitis B and Hepatitis C Screening VERSUS None IN Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,30408079,Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,Both Hepatitis B and Hepatitis C Screening,Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.,None,NE
2018-01-28565,2018,Suijkerbuijk 2018 PLoS One,6500,Hepatitis B Screening VERSUS None IN Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,30408079,Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,Hepatitis B Screening,Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.,None,NE
2018-01-28565,2018,Suijkerbuijk 2018 PLoS One,7800,Hepatitis C Screening VERSUS None IN Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,30408079,Healthy; Age- Unknown; Gender- Both; Country- Netherlands; Other- Migrants from Cape Verde.,Hepatitis C Screening,Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.,None,NE
1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
